Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein

Neuropathological stageing of Alzheimer-related changes.

Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123

Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy

Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359

Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668

Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease

Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., & Crowther, R. A. (1989) · Neuron · doi:10.1016/0896-6273(89)90210-9 · Cited by 2,492

A68: a Major Subunit of Paired Helical Filaments and Derivatized Forms of Normal Tau

Lee, V. M.-Y., Balin, B. J., Otvos, L., & Trojanowski, J. Q. (1991) · Science · doi:10.1126/science.1899488 · Cited by 1,418

Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau

Goedert, M., Wischik, C. M., Crowther, R. A., Walker, J. E., & Klug, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.11.4051 · Cited by 1,134

Tau proteins of alzheimer paired helical filaments: Abnormal phosphorylation of all six brain isoforms

Goedert, M., Spillantini, M. G., Cairns, N. J., & Crowther, R. A. (1992) · Neuron · doi:10.1016/0896-6273(92)90117-v · Cited by 1,122

Cloning and sequencing of the cDNA encoding an isoform of microtubule‐associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain.

Goedert, M., Spillantini, M. G., Potier, M. C., Ulrich, J., & Crowther, R. A. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03390.x · Cited by 1,037

Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization.

Goedert, M., & Jakes, R. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07870.x · Cited by 929

Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding

Bramblett, G. T., Goedert, M., Jakes, R., Merrick, S. E., Trojanowski, J. Q., & Lee, V. M. Y. (1993) · Neuron · doi:10.1016/0896-6273(93)90057-x · Cited by 903

Comparison of the neurofibrillary pathology in Alzheimer’s disease and familial presenile dementia with tangles

Spillantini, M. G., Crowther, R. A., & Goedert, M. (1996) · Acta Neuropathologica · doi:10.1007/s004010050487 · Cited by 160

Normal and Pathological Tau Proteins as Factors for Microtubule Assembly

Delacourte, A., & Buée, L. (1997) · International review of cytology · doi:10.1016/s0074-7696(08)62588-7 · Cited by 145

Early axonopathy preceding neurofibrillary tangles in mutant tau transgenic mice

Leroy, K., Bretteville, A., Schindowski, K., Gilissen, E., Authelet, M., De Decker, R., Yilmaz, Z., Buée, L., & Brion, J.-P. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070345 · Cited by 135

Cholesterol‐dependent modulation of tau phosphorylation in cultured neurons

Fan, Q., Yu, W., Senda, T., Yanagisawa, K., & Michikawa, M. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00063.x · Cited by 136

Identification of O-GlcNAc sites within peptides of the Tau protein and their impact on phosphorylation

Smet‐Nocca, C., Broncel, M., Wieruszeski, J., Tokarski, C., Hanoulle, X., Leroy, A., Landrieu, I., Rolando, C. H., Lippens, G. M., & Hackenberger, C. P. R. (2011) · Molecular BioSystems · doi:10.1039/c0mb00337a · Cited by 141

Pick's disease associated with the novel Tau gene mutation K369I

Neumann, M., Schulz‐Schaeffer, W., Crowther, R. A., Smith, M. J., Spillantini, M. G., Goedert, M., & Kretzschmar, H. A. (2001) · Annals of Neurology · doi:10.1002/ana.1223 · Cited by 134

Aberrant Tau Phosphorylation by Glycogen Synthase Kinase-3β and JNK3 Induces Oligomeric Tau Fibrils in COS-7 Cells

Sato, S., Tatebayashi, Y., Akagi, T., Chui, D.-H., Murayama, M., Miyasaka, T., Planel, E., Tanemura, K., Sun, X., Hashikawa, T., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202241200 · Cited by 135

Insulin dysfunction and Tau pathology

Khoury, N. B. E., Gratuze, M., Papon, M.-A., Bretteville, A., & Planel, E. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00022 · Cited by 133

Down-regulation of WW Domain-containing Oxidoreductase Induces Tau Phosphorylation in Vitro

Sze, C.-I., Su, M., Pugazhenthi, S., Jambal, P., Hsu, L.-J., Heath, J., Schultz, L., & Chang, N.-S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401399200 · Cited by 130

Phosphorylation-mimicking glutamate clusters in the proline-rich region are sufficient to simulate the functional deficiencies of hyperphosphorylated tau protein

Eidenmüller, J., Fath, T., Maas, T., Pool, M., Sontag, E., & Brandt, R. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3570759 · Cited by 135

Distinct FTDP-17 Missense Mutations in Tau Produce Tau Aggregates and Other Pathological Phenotypes in Transfected CHO Cells

Vogelsberg-Ragaglia, V., BRUCE, J. S., Richter‐Landsberg, C., Zhang, B., Hong, M., Trojanowski, J. Q., & Lee, V. M. ‐. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.12.4093 · Cited by 129

Axonal Degeneration Induced by Targeted Expression of Mutant Human Tau in Oligodendrocytes of Transgenic Mice That Model Glial Tauopathies

Higuchi, M., Zhang, B., Forman, M. S., Yoshiyama, Y., Trojanowski, J. Q., & Lee, V. M. ‐. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.2691-05.2005 · Cited by 133

Cortical and brainstem-type Lewy bodies are immunoreactive for the cyclin-dependent kinase 5.

Brion, J., & Couck, A. M. (1995) · Europe PMC (PubMed Central) · Cited by 125

Dual modification of Alzheimer’s disease PHF-tau protein by lysine methylation and ubiquitylation: a mass spectrometry approach

Thomas, S. N., Funk, K. E., Wan, Y., Liao, Z., Davies, P., Kuret, J., & Yang, A. J. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0893-0 · Cited by 123

Analysis of Tau Phosphorylation and Truncation in a Mouse Model of Human Tauopathy

Delobel, P., Lavenir, I., Fraser, G. M., Ingram, E., Holzer, M., Ghetti, B. F., Spillantini, M. G., Crowther, R. A., & Goedert, M. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070627 · Cited by 124

Dishevelled Regulates the Metabolism of Amyloid Precursor Protein via Protein Kinase C/Mitogen-Activated Protein Kinase and c-Jun Terminal Kinase

Mudher, A. K., Chapman, S. C., Richardson, J. C., Asuni, A. A., Gibb, G., Pollard, C. C., Killick, R., Iqbal, T. A., Raymond, F. L., Varndell, I. M., et al. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-14-04987.2001 · Cited by 122

The Physiological Link between Metabolic Rate Depression and Tau Phosphorylation in Mammalian Hibernation

Stieler, J., Bullmann, T., Kohl, F., Tøien, Ø., Brückner, M. K., Härtig, W., Barnes, B. M., & Arendt, T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0014530 · Cited by 123

Genetic Creutzfeldt-Jakob disease associated with the E200K mutation: characterization of a complex proteinopathy

Kovács, G. G., Seguin, J., Quadrio, I., Höftberger, R., Kapás, I., Streichenberger, N., Biacabé, A.-G., Meyronet, D., Sciot, R., Vandenberghe, R. R., et al. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0713-y · Cited by 118

Structural and Functional Implications of Tau Hyperphosphorylation: Information from Phosphorylation-Mimicking Mutated Tau Proteins

Eidenmüller, J., Fath, T., Hellwig, A., Reed, J., Sontag, E., & Brandt, R. (2000) · Biochemistry · doi:10.1021/bi001290z · Cited by 117

A novel, ultrasensitive assay for tau: potential for assessing traumatic brain injury in tissues and biofluids.

Rubenstein, R., Chang, B., Davies, P., Wagner, A. K., Robertson, C. S., & Wang, K. K. W. (2015) · Journal of Neurotrauma · doi:10.1089/neu.2014.3548 · Cited by 116

Synaptic tau: A pathological or physiological phenomenon?

Robbins, M., Clayton, E. L., & Schierle, G. S. K. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01246-y · Cited by 128

Tau Protein and the Neurofibrillary Pathology of Alzheimer's Disease

Goedert, M. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb34410.x · Cited by 115

Argyrophilic grain disease: widespread hyperphosphorylation of tau protein in limbic neurons

Tolnay, M., Spillantini, M. G., Goedert, M., ULRICH, J., Langui, D., & Probst, A. (1997) · Acta Neuropathologica · doi:10.1007/s004010050642 · Cited by 115

Site-specific Phosphorylation and Caspase Cleavage Differentially Impact Tau-Microtubule Interactions and Tau Aggregation

Ding, H., Matthews, T. A., & Johnson, G. V. W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511697200 · Cited by 112

Functional genomic screen and network analysis reveal novel modifiers of tauopathy dissociated from tau phosphorylation

Ambegaokar, S. S., & Jackson, G. R. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr432 · Cited by 113

Cooexpression of FTDP-17 tau and GSK-3β in transgenic mice induce tau polymerization and neurodegeneration

Engel, T., Lucas, J. J., Gómez‐Ramos, P., Morán, M. A., Ávila, J., & Hernández, F. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.06.010 · Cited by 111

Methylation as a key regulator of Tau aggregation and neuronal health in Alzheimer’s disease

Balmik, A. A., & Chinnathambi, S. (2021) · Cell Communication and Signaling · doi:10.1186/s12964-021-00732-z · Cited by 110

Mitotic-like Tau Phosphorylation by p25-Cdk5 Kinase Complex

Hamdane, M., Sambo, A., Delobel, P., Bégard, S., Violleau, A., Delacourte, A., Bertrand, P., Bénavidès, J., & Buée, L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302872200 · Cited by 107

Staging of Alzheimer's Pathology in Triple Transgenic Mice: A Light and Electron Microscopic Analysis

Oh, K.-J., Perez, S. E., Lagalwar, S., Vana, L., Binder, L., & Mufson, E. J. (2010) · International Journal of Alzheimer's Disease · doi:10.4061/2010/780102 · Cited by 105

Alzheimer disease specific phosphoepitopes of Tau interfere with assembly of tubulin but not binding to microtubules

Amniai, L., Barbier, P., Sillen, A., Wieruszeski, J.-M., Peyrot, V., Lippens, G., & Landrieu, I. (2009) · The FASEB Journal · doi:10.1096/fj.08-121590 · Cited by 105

Lithium treatment arrests the development of neurofibrillary tangles in mutant tau transgenic mice with advanced neurofibrillary pathology.

Leroy, K., Ando, K., Héraud, C., Yilmaz, Z., Authelet, M., Boeynaems, J.-M., Buée, L., De Decker, R., & Brion, J.-P. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1276 · Cited by 103

A Useful Approach to Identify Novel Small-Molecule Inhibitors of Wnt-Dependent Transcription

Ewan, K., Pająk, B., Stubbs, M., Todd, H., Barbeau, O. R., Quevedo, C. E., Botfield, H. F., Young, R., Ruddle, R. R., Samuel, L. J., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1028 · Cited by 102

p35/Cdk5 pathway mediates soluble amyloid‐β peptide‐induced tau phosphorylation in vitro

Town, T., Zolton, J., Shaffner, R., Schnell, B., Crescentini, R. M., Wu, Y., Zeng, J., DelleDonne, A., Obregon, D. F., Tan, J., et al. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10299 · Cited by 102

Cell cycle-dependent phosphorylation and microtubule binding of tau protein stably transfected into Chinese hamster ovary cells.

Preuß, U., Döring, F., Illenberger, S., & Mandelkow�, E. (1995) · Molecular Biology of the Cell · doi:10.1091/mbc.6.10.1397 · Cited by 101

Protein coding of neurodegenerative dementias: the neuropathological basis of biomarker diagnostics

Kovács, G. G., Botond, G., & Budka, H. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0658-1 · Cited by 102

Filamentous Tau Pathology in Nerve Cells, Astrocytes, and Oligodendrocytes of Aged Baboons

Schultz, C., Dehghani, F., Hubbard, G. B., Thal, D. R., Struckhoff, G., Braak, E., & Braak, H. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.1.39 · Cited by 101

Human misfolded truncated tau protein promotes activation of microglia and leukocyte infiltration in the transgenic rat model of tauopathy

Žilka, N., Stožická, Z., Kováč, A., Pilipcinec, E., Bugos, O., & Novák, M. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.01.013 · Cited by 101

Axonal inclusions in spinocerebellar ataxia type 3

Seidel, K., den Dunnen, W. F. A., Schultz, C., Paulson, H. L., Frank, S., de Vos, R. A., Brunt, E. R. P., Deller, T., Kampinga, H. H., & Rüb, U. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0717-7 · Cited by 98

N‐Acetyl‐ l ‐cysteine protects SHSY5Y neuroblastoma cells from oxidative stress and cell cytotoxicity: effects on β‐amyloid secretion and tau phosphorylation

Olivieri, G., Baysang, G., Meier, F., Müller-Spahn, F., Stähelin, H. B., Brockhaus, M., & Brack, C. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00090.x · Cited by 98

Tau-mediated synaptic damage in Alzheimer’s disease

Jadhav, S., Cubinkova, V., Zimova, I., Brezováková, V., Maďari, A., Cigánková, V., & Žilka, N. (2015) · Translational Neuroscience · doi:10.1515/tnsci-2015-0023 · Cited by 97

Molecular dissection of the paired helical filament

Goedert, M., Spillantini, M. G., Jakes, R., Crowtherp, R. A., Vanmechelen, E., Probst, A., Götz, J., Bürki, K., & Cohen, P. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00017-9 · Cited by 94

Cdc2 phosphorylation of nucleolin demarcates mitotic stages and Alzheimer’s disease pathology

Dranovsky, A., Vincent, I. J., Gregori, L. L., Schwarzman, A. L., Colflesh, D. E., Enghild, J. J., Strittmatter, W. J., Davies, P., & Goldgaber, D. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00248-7 · Cited by 92

Structural characterization by nuclear magnetic resonance of the impact of phosphorylation in the proline‐rich region of the disordered Tau protein

Sibille, N., Huvent, I., Fauquant, C., Verdegem, D., Amniai, L., Leroy, A., Wieruszeski, J., Lippens, G. M., & Landrieu, I. (2011) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.23210 · Cited by 101

The Low Density Lipoprotein Receptor-related Protein 6 Interacts with Glycogen Synthase Kinase 3 and Attenuates Activity

Mi, K., Dolan, P. J., & Johnson, G. V. W. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508657200 · Cited by 90

Plasma p‐tau immunoassays in clinical research for Alzheimer's disease

Teunissen, C. E., Kolster, R., Triana‐Baltzer, G., Janelidze, S., Zetterberg, H., & Kolb, H. C. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14397 · Cited by 96

Characterisation of cytoskeletal abnormalities in mice transgenic for wild-type human tau and familial Alzheimer's disease mutants of APP and presenilin-1

Boutajangout, A., Authelet, M., Blanchard, V., Touchet, N., Tremp, G. L., Pradier, L., & Brion, J. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.09.007 · Cited by 90

The central role of tau in Alzheimer’s disease: From neurofibrillary tangle maturation to the induction of cell death

Thal, D. R., & Tomé, S. O. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.10.006 · Cited by 92

Amyloid‐β‐induced toxicity of primary neurons is dependent upon differentiation‐associated increases in tau and cyclin‐dependent kinase 5 expression

Liu, T., Perry, G. L., Chan, H. W., Verdile, G., Martins, R. N., Smith, M. A., & Atwood, C. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02196.x · Cited by 85

Inverse association of Pin1 and tau accumulation in Alzheimer's disease hippocampus

Holzer, M., Gärtner, U., Stöbe, A., Härtig, W., Gruschka, H., Brückner, M. K., & Arendt, T. (2002) · Acta Neuropathologica · doi:10.1007/s00401-002-0581-1 · Cited by 86

Genetic Modulation of Tau Phosphorylation in the Mouse

Brich, J., Shie, F., Howell, B. W., Li, R., Tus, K., Wakeland, E. K., Jin, L., Mumby, M. C., Churchill, G. A., Herz, J., et al. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-01-00187.2003 · Cited by 84

Muscarinic agonists reduce tau phosphorylation in non-neuronal cells via GSK-3β inhibition and in neurons

Forlenza, O. V., Spink, J. M., Dayanandan, R., Anderton, B. H., Olesen, O. F., & Lovestone, S. (2000) · Journal of Neural Transmission · doi:10.1007/s007020070034 · Cited by 85

Role of GSK‐3β in Alzheimer's disease pathology

Planel, E., Sun, X., & Takashima, A. (2002) · Drug Development Research · doi:10.1002/ddr.10100 · Cited by 87

Tau protein in the glial cytoplasmic inclusions of multiple system atrophy can be distinguished from abnormal tau in Alzheimer's disease

Cairns, N. J., Atkinson, P. F., Hanger, D. P., Anderton, B. H., Daniel, S. E., & Lantos, P. L. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00474-6 · Cited by 85

The Peptidyl Prolyl cis/trans-Isomerase Pin1 Recognizes the Phospho-Thr212-Pro213 Site on Tau

Smet‐Nocca, C., Sambo, A., Wieruszeski, J., Leroy, A., Landrieu, I., Buée, L., & Lippens, G. M. (2004) · Biochemistry · doi:10.1021/bi035479x · Cited by 84

Pin1 colocalization with phosphorylated tau in Alzheimer's disease and other tauopathies

Ramakrishnan, P., Dickson, D. W., & Davies, P. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(03)00109-8 · Cited by 84

Fibrillogenic Nuclei Composed of P301L Mutant Tau Induce Elongation of P301L Tau but Not Wild-type Tau

Aoyagi, H., Hasegawa, M., & Tamaoka, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611876200 · Cited by 83

Variable phenotypic expression and extensive tau pathology in two families with the novel tau mutation L315R

van Herpen, E., Rosso, S. M., Serverijnen, L., Yoshida, H., Breedveld, G. J., van de Graaf, R., Kamphorst, W., Ravid, R., Willemsen, R., Dooijes, D., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10721 · Cited by 83

Modeling Alzheimer's disease with non-transgenic rat models

Lecanu, L., & Papadopoulos, V. (2013) · Alzheimer s Research & Therapy · doi:10.1186/alzrt171 · Cited by 83

Accelerated Human Mutant Tau Aggregation by Knocking Out Murine Tau in a Transgenic Mouse Model

Ando, K., Leroy, K., Héraud, C., Yilmaz, Z., Authelet, M., Suain, V., Decker, R. D., & Brion, J. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2010.10.034 · Cited by 80

Is Huntington's disease a tauopathy?

Gratuze, M., Cisbani, G., Cicchetti, F., & Planel, E. (2016) · Brain · doi:10.1093/brain/aww021 · Cited by 81

Increased Levels of Tau Protein in SH‐SY5Y Cells After Treatment with Cholinesterase Inhibitors and Nicotinic Agonists

Hellström‐Lindahl, E., Moore, H., & Nordberg, A. K. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.740777.x · Cited by 81

Coexpression of Human cdk5 and Its Activator p35 with Human Protein Tau in Neurons in Brain of Triple Transgenic Mice

den Haute, C. V., Spittaels, K., Dorpe, J. V., Lasrado, R., Vandezande, K., Laenen, I., Geerts, H., & Leuven, F. V. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0333 · Cited by 81

Site-specific Dephosphorylation of Tau Protein at Ser202/Thr205 in Response to Microtubule Depolymerization in Cultured Human Neurons Involves Protein Phosphatase 2A

Merrick, S. E., Demoise, D. C., & Lee, V. M. ‐. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.10.5589 · Cited by 81

Increased misfolding and truncation of tau in APP/PS1/tau transgenic mice compared to mutant tau mice

Héraud, C., Goufak, D., Ando, K., Leroy, K., Suain, V., Yilmaz, Z., De Decker, R., Authelet, M., Laporte, V., Octave, J.-N., et al. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.09.010 · Cited by 80

Neuronal and Astrocytic Extracellular Vesicle Biomarkers in Blood Reflect Brain Pathology in Mouse Models of Alzheimer’s Disease

Delgado‐Peraza, F., Nogueras‐Ortiz, C. J., Volpert, O. V., Liu, D., Goetzl, E. J., Mattson, M. P., Greig, N. H., Eitan, E., & Kapogiannis, D. (2021) · Cells · doi:10.3390/cells10050993 · Cited by 81

Microtubule-associated protein tau, heparan sulphate and α-synuclein in several neurodegenerative diseases with dementia

Spillantini, M. G., Tolnay, M., Love, S., & Goedert, M. (1999) · Acta Neuropathologica · doi:10.1007/s004010051034 · Cited by 78

Methylene blue fails to inhibit Tau and polyglutamine protein dependent toxicity in zebrafish

van Bebber, F., Paquet, D., Hruscha, A., Schmid, B., & Haass, C. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.03.023 · Cited by 79

Phosphorylation of microtubule‐associated protein tau by stress‐activated protein kinases in intact cells

Buée‐Scherrer, V., & Goedert, M. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02460-2 · Cited by 76

Disruption of the cytoskeleton in Alzheimer's disease

Lee, V. M. ‐. (1995) · Current Opinion in Neurobiology · doi:10.1016/0959-4388(95)80073-5 · Cited by 75

Chapter 21 Neurofibrillary pathology of Alzheimer's disease and other tauopathies

Goedert, M. (1998) · Progress in brain research · doi:10.1016/s0079-6123(08)64022-4 · Cited by 77

Phosphorylated tau sites that are elevated in Alzheimer's disease fluid biomarkers are visualized in early neurofibrillary tangle maturity levels in the post mortem brain

Moloney, C. M., Labuzan, S. A., Crook, J. E., Siddiqui, H., Castanedes‐Casey, M., Lachner, C., Petersen, R. C., Duara, R., Graff‐Radford, N. R., Dickson, D. W., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12749 · Cited by 76

Abnormal Tau phosphorylation of the Alzheimer‐type also occurs during mitosis

Delobel, P., Flament, S., Hamdane, M., Vanbesien-Mailliot, C., Sambo, A., Bégard, S., Sergeant, N., Delacourte, A., Vilain, J., & Buée, L. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01143.x · Cited by 73

Alzheimer's Disease and Anesthesia

Papon, M.-A., Whittington, R. A., Khoury, N. B. E., & Planel, E. (2011) · Frontiers in Neuroscience · doi:10.3389/fnins.2010.00272 · Cited by 70

Endogenous Aβ causes cell death via early tau hyperphosphorylation

Amadoro, G., Corsetti, V., Ciotti, M. T., Florenzano, F., Capsoni, S., Amato, G., & Calissano, P. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.06.005 · Cited by 74

Hyperphosphorylated tau in the brains of mice and monkeys with long-term administration of ketamine

Yeung, L. Y., Wai, M. S. M., Fan, M., Mak, Y. T., Lam, W. P., Li, Z., Lü, G., & Yew, D. T. W. (2010) · Toxicology Letters · doi:10.1016/j.toxlet.2010.01.008 · Cited by 72

Attenuated Neurodegenerative Disease Phenotype in Tau Transgenic Mouse Lacking Neurofilaments

Ishihara, T., Higuchi, M., Zhang, B., Yoshiyama, Y., Hong, M., Trojanowski, J. Q., & Lee, V. M. ‐. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-16-06026.2001 · Cited by 71

High–Molecular-Weight Paired Helical Filaments from Alzheimer Brain Induces Seeding of Wild-Type Mouse Tau into an Argyrophilic 4R Tau Pathology in Vivo

Audouard, E., Houben, S., Masaracchia, C., Yilmaz, Z., Suain, V., Authelet, M., Decker, R. D., Buée, L., Boom, A., Leroy, K., et al. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.06.008 · Cited by 73

Phosphorylation of tau in apolipoprotein E-deficient mice

Genis, I., Gordon, I., Sehayek, E., & Michaelson, D. M. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12007-q · Cited by 70

Molecular Implication of PP2A and Pin1 in the Alzheimer's Disease Specific Hyperphosphorylation of Tau

Landrieu, I., Smet‐Nocca, C., Amniai, L., Louis, J. V., Wieruszeski, J., Goris, J., Janssens, V., & Lippens, G. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021521 · Cited by 71

Deferiprone Reduces Amyloid-β and Tau Phosphorylation Levels but not Reactive Oxygen Species Generation in Hippocampus of Rabbits Fed a Cholesterol-Enriched Diet

Prasanthi, J. R. P., Schrag, M., Dasari, B., Marwarha, G., Dickson, A., Kirsch, W. M., & Ghribi, O. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111346 · Cited by 68

Postmortem changes in the phosphorylation state of tau-protein in the rat brain

Gärtner, U., Janke, C., Holzer, M., Vanmechelen, E., & Arendt, T. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00094-3 · Cited by 66

Direct interaction of soluble human recombinant tau protein with Aβ 1–42 results in tau aggregation and hyperphosphorylation by tau protein kinase II

Rank, K. B., Pauley, A. M., Bhattacharya, K., Wang, Z., EVANS, D. B., Fleck, T. J., Johnston, J. A., & Sharma, S. K. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02376-1 · Cited by 66

The Environmental Toxin Arsenite Induces Tau Hyperphosphorylation

Giasson, B. I., Sampathu, D. M., Wilson, C., Vogelsberg-Ragaglia, V., Mushynski, W. E., & Lee, V. M. ‐. (2002) · Biochemistry · doi:10.1021/bi026813c · Cited by 66

Mitotic phosphorylation of tau protein in neuronal cell lines resembles phosphorylation in Alzheimer's disease

Preuß, U., & Mandelkow, E. (1998) · European Journal of Cell Biology · doi:10.1016/s0171-9335(98)80032-0 · Cited by 66

The interrelationship between selective tau phosphorylation and microtubule association

Xie, H., Litersky, J. M., Hartigan, J. A., Jope, R. S., & Johnson, G. V. W. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00407-7 · Cited by 66

GSK3α exhibits β‐catenin and tau directed kinase activities that are modulated by Wnt

Asuni, A. A., Hooper, C., Reynolds, C. H., Lovestone, S., Anderton, B. H., & Killick, R. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05243.x · Cited by 64

Tau Phosphorylation and Aggregation in the Developing Human Brain

Hefti, M. M., Kim, S., Bell, A. J., Betters, R. K., Fiock, K. L., Iida, M. A., Smalley, M. E., Farrell, K. W., Fowkes, M. E., & Crary, J. F. (2019) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlz073 · Cited by 67

H untington's D isease ( HD ): Degeneration of Select Nuclei, Widespread Occurrence of Neuronal Nuclear and Axonal Inclusions in the Brainstem

Rüb, U., Hentschel, M., Stratmann, K., Brunt, E. R. P., Heinsen, H., Seidel, K., Bouzrou, M., Auburger, G. W. J., Paulson, H. L., Vonsattel, J., et al. (2013) · Brain Pathology · doi:10.1111/bpa.12115 · Cited by 63

Modulation of tau phosphorylation and intracellular localization by cellular stress

Jenkins, S. M., ZINNERMAN, M., Garner, C. C., & Johnson, G. V. W. (2000) · Biochemical Journal · doi:10.1042/bj3450263 · Cited by 63

Deregulation of Protein Phosphatase 2A and Hyperphosphorylation of τ Protein Following Onset of Diabetes in NOD Mice

Papon, M.-A., Khoury, N. B. E., Marcouiller, F., Julien, C., Morin, F., Bretteville, A., Petry, F. R., Gaudreau, S., Amrani, A., Mathews, P. M., et al. (2012) · Diabetes · doi:10.2337/db12-0187 · Cited by 60

Major Differences between the Self-Assembly and Seeding Behavior of Heparin-Induced and in Vitro Phosphorylated Tau and Their Modulation by Potential Inhibitors

Despres, C., Di, J., Cantrelle, F., Li, Z., Huvent, I., Chambraud, B., Zhao, J., Chen, J., Chen, S., Lippens, G. M., et al. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.9b00325 · Cited by 61

Structural Basis of Tau Interaction With BIN1 and Regulation by Tau Phosphorylation

Lasorsa, A., Malki, I., Cantrelle, F.-X., Merzougui, H., Boll, E., Lambert, J.-C., & Landrieu, I. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00421 · Cited by 58

Cholinergic Surveillance over Hippocampal RNA Metabolism and Alzheimer's-Like Pathology

Kolisnyk, B., Al‐Onaizi, M., Soreq, L., Barbash, S., Bekenstein, U., Haberman, N., Hanin, G., Kish, M. T., da Silva, J. S., Fahnestock, M. L., et al. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhw177 · Cited by 56

Screening of tau protein kinase inhibitors in a tauopathy-relevant cell-based model of tau hyperphosphorylation and oligomerization

Yadikar, H., Torres, I., Aiello, G., Kurup, M., Yang, Z., Lin, F. Y., Kobeissy, F. H., Yost, R. A., & Wang, K. (2020) · PLoS ONE · doi:10.1371/journal.pone.0224952 · Cited by 58

The Role and Pathogenesis of Tau Protein in Alzheimer’s Disease

Hong, X., Huang, L., Lei, F., Tian, L., Luo, Y., Zeng, M., & Wang, Z. (2025) · Biomolecules · doi:10.3390/biom15060824 · Cited by 67

Rapid Tau Protein Dephosphorylation and Differential Rephosphorylation during Cardiac Arrest-Induced Cerebral Ischemia and Reperfusion

Vanbesien-Mailliot, C., Podevin-Dimster, V., Rosenthal, R. E., Sergeant, N., Delacourte, A., Fiskum, G. M., & Buée, L. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200003000-00013 · Cited by 57

P‐tau235: a novel biomarker for staging preclinical Alzheimer’s disease

Lantero‐Rodriguez, J., Snellman, A., Benedet, A. L., Milà‐Alomà, M., Camporesi, E., Montoliu‐Gaya, L., Ashton, N. J., Vrillon, A., Karikari, T. K., Gispert, J. D., et al. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202115098 · Cited by 59

Proteasome inhibition and Tau proteolysis: an unexpected regulation

Delobel, P., Leroy, O., Hamdane, M., Sambo, A., Delacourte, A., & Buée, L. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.11.018 · Cited by 55

Spinal Cord Neurofibrillary Pathology in Alzheimer Disease and Guam Parkinsonism-Dementia Complex

Schmidt, M. L., Zhukareva, V. A., Perl, D. P., Sheridan, S. K., Schuck, T., Lee, V. M. ‐., & Trojanowski, J. Q. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.11.1075 · Cited by 55

Classification accuracy of blood-based and neurophysiological markers in the differential diagnosis of Alzheimer’s disease and frontotemporal lobar degeneration

Benussi, A., Cantoni, V., Rivolta, J., Archetti, S., Micheli, A., Ashton, N., Zetterberg, H., Blennow, K., & Borroni, B. (2022) · Alzheimer's Research & Therapy · doi:10.1186/s13195-022-01094-5 · Cited by 53

Unique Alzheimer's Disease Paired Helical Filament Specific Epitopes Involve Double Phosphorylation at Specific Sites

Hoffmann, R., Lee, V. M. ‐., Leight, S., Varga, I., & Ötvös, L. (1997) · Biochemistry · doi:10.1021/bi970380+ · Cited by 152

The extent of phosphorylation of fetal tau is comparable to that of PHF-tau from Alzheimer paired helical filaments

Kenessey, Á., & Yen, S.-H. C. (1993) · Brain Research · doi:10.1016/0006-8993(93)90478-6 · Cited by 175

The abnormal phosphorylation of tau protein at Ser-202 in Alzheimer disease recapitulates phosphorylation during development.

Goedert, M., Jakes, R., Crowther, R. A., Six, J., Lübke, U., Vandermeeren, M., Cras, P., Trojanowski, J. Q., & Lee, V. M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.11.5066 · Cited by 446

404 Molecular characterization of the epitopes of two anti PHF-Tau monoclonal antibodies used in an immunoassay for the mapping of neurofibrillary degeneration in Alzheimer's disease

Gougat, C., Perachon, S., Goedert, M., Condamines, O., Delacourte, A., Pau, B., Granier, C., & Mourton-Gilles, C. (1996) · Neurobiology of Aging · doi:10.1016/s0197-4580(96)80406-4

Developmental Changes in τ Phosphorylation: Fetal τ Is Transiently Phosphorylated in a Manner Similar to Paired Helical Filament‐τ Characteristic of Alzheimer's Disease

Brion, J., Smith, C. J., Couck, A., Gallo, J., & Anderton, B. H. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb07444.x · Cited by 202